Fate Therapeutics Lands New Funding

  • Feed Type
  • Date
  • Company Name
    Fate Therapeutics
  • Mailing Address
    3535 General Atomics Court San Diego, CA 92121
  • Company Description
    The company’s revolutionary platform focuses on both regenerative and reprogramming medicine. Fate’s regenerative medicine platform involves developing drugs that awaken adult stem cells in the body to repair damaged cells and tissues. Fate’s reprogramming medicine platform involves developing drugs to reprogram mature adult cells into stem cells which when differentiated can become healthy heart, bone, brain or other tissues.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Takeda Ventures